Metraipolis › archive › dc_8f670327beae

Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in… — Europe PMC PMID:41440537

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41440537
DOI
10.3390/medsci13040305
License (as archived)
solo-consultazione
Archived
2026-11-07T21:26:48.598Z
SHA-256 of the archived text
8aca5cb0a67c651e3ba229f22f8a8ee9df84635991bed13fac1ea487b5ae3296
Stable URL of this page
https://metraipolis.com/documento/dc_8f670327beae

How to cite

Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in… — Europe PMC PMID:41440537 — Europe PMC (en), https://europepmc.org/article/MED/41440537 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8f670327beae (Metraipolis archive dc_8f670327beae, sha256 8aca5cb0a67c651e3ba229f22f8a8ee9df84635991bed13fac1ea487b5ae3296)
BibTeX
@misc{dc8f670327beae,
  title = {Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in… — Europe PMC PMID:41440537},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41440537},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8f670327beae; sha256 8aca5cb0a67c651e3ba229f22f8a8ee9df84635991bed13fac1ea487b5ae3296},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41440537. Agents can read the archived copy with the MCP tool read_document.